| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (13709 + methicillin-susceptible) |
- |
- |
4 － ? |
Linezolid (PNU-100766, U-100766, Zyvox)  |
269 |
| Staphylococcus aureus (14-354 + serial passage) |
- |
- |
2 － ? |
REP8839 |
789 |
| Staphylococcus aureus (14-354 + serial passage) |
- |
- |
8 － ? |
REP8839 |
789 |
| Staphylococcus aureus (14379 + glycopeptide-intermediate-resistant) |
- |
- |
0.008 － ? |
Rifampicin (Rifampin) |
235 |
| Staphylococcus aureus (14379 + glycopeptide-intermediate-resistant) |
- |
- |
0.25 － ? |
Doxycycline (Doxycycline hyclate, Doxy, Vibra, Vibramycin) |
235 |
| Staphylococcus aureus (14379 + glycopeptide-intermediate-resistant) |
- |
- |
0.25 － ? |
Tigecycline (GAR-936, Tigacyl) |
235 |
| Staphylococcus aureus (14379 + glycopeptide-intermediate-resistant) |
- |
- |
8 － ? |
Vancomycin (Vancocyn, Lyphocin) |
235 |
| Staphylococcus aureus (14379 + glycopeptide-intermediate-resistant) |
- |
- |
64 － ? |
Gentamicin (Gentamycin, Garamycin) |
235 |
| Staphylococcus aureus (145M + methicillin-resistant) |
- |
- |
0.39 － ? |
Mupirocin (Bactroban) |
734 |
| Staphylococcus aureus (145M + methicillin-resistant) |
- |
- |
3.13 － ? |
Bidwillon B |
734 |
| Staphylococcus aureus (14d) |
- |
- |
0.5 － ? |
Tigecycline (GAR-936, Tigacyl) |
322 |
| Staphylococcus aureus (150 + methicillin-resistant + ESBL) |
- |
- |
>32 － ? |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
1055 |
| Staphylococcus aureus (150 + methicillin-resistant + ESBL) |
- |
- |
>256 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
1055 |
| Staphylococcus aureus (15187 + methicillin-resistant) |
- |
- |
>16 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
180 |
| Staphylococcus aureus (16 + methicillin-resistant) |
- |
- |
0.5 － ? |
Oritavancin (LY333328) |
207 |
| Staphylococcus aureus (16 + methicillin-resistant) |
- |
- |
0.5 － ? |
Quinupristin/Dalfopristin (Synercid) |
207 |
| Staphylococcus aureus (16 + methicillin-resistant) |
- |
- |
1 － ? |
Daptomycin (Cubicin) |
207 |
| Staphylococcus aureus (16 + methicillin-resistant) |
- |
- |
1 － ? |
LBM415 (NVP-PDF-713, VIC-10495) |
207 |
| Staphylococcus aureus (16 + methicillin-resistant) |
- |
- |
1 － ? |
Teicoplanin (Targocid) |
207 |
| Staphylococcus aureus (16 + methicillin-resistant) |
- |
- |
2 － ? |
Vancomycin (Vancocyn, Lyphocin) |
207 |
| Staphylococcus aureus (16 + methicillin-resistant) |
- |
- |
4 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
207 |
| Staphylococcus aureus (16 + methicillin-resistant) |
- |
- |
4 － ? |
Ranbezolid (RBX 7644) |
207 |
| Staphylococcus aureus (16 + methicillin-resistant) |
- |
- |
8 － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
207 |
| Staphylococcus aureus (16 + methicillin-resistant) |
- |
- |
16 － ? |
Gatifloxacin (Tequin) |
207 |
| Staphylococcus aureus (16 + methicillin-resistant) |
- |
- |
>32 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
207 |
| Staphylococcus aureus (16 + methicillin-resistant) |
- |
- |
32 － ? |
Levofloxacin (Levaquin, Quixin) |
207 |
| Staphylococcus aureus (16) |
- |
- |
0.5 － ? |
Gentamicin (Gentamycin, Garamycin) |
247 |
| Staphylococcus aureus (1-63) |
- |
- |
0.06 － ? |
Clindamycin (Cleocin) |
621 |